首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >Antidiabetic effect of Drymaria cordata leaf against streptozotocin–nicotinamide-induced diabetic albino rats
【24h】

Antidiabetic effect of Drymaria cordata leaf against streptozotocin–nicotinamide-induced diabetic albino rats

机译:Drymaria Cordata叶对链脲佐菌素 - 烟酰胺诱导糖尿病白化大鼠的抗糖尿病作用

获取原文
       

摘要

Drymaria cordata (Caryophyllaceae), commonly known as Abhijalo in Sikkimese-Tibetan, is a creeping herb grown in tropical and subtropical regions of the world. It is used by ethnic groups of Sikkim, North-East India, for the treatment of various diseases including diabetes. This study aimed to investigate the antidiabetic effect of methanol extract from D. cordata leaf (DCME) in streptozotocin (STZ) and nicotinamide (NA)-induced type 2 diabetes in rats. Diabetic Wistar albino rats were treated with DCME at 200 mg/kg and 400 mg/kg orally for 28 days. Metformin (150 mg/kg b.w.) was used as a reference drug. Fasting blood glucose (FBG) level; serum biochemical parameters; and liver, kidney, and antioxidant parameters were estimated, and pancreatic histopathology was performed after 28 days of treatment. Administration of DCME to STZ-NA-induced diabetic rats at 200 mg/kg and 400 mg/kg orally for 28 days exhibited statistically significant (P 0.05) and dose-dependent reduction of FBG, glycosylated hemoglobin, serum lipid, and hepatorenal antioxidative parameters in DCME-treated groups when compared to those of diabetic controls. Histopathological studies of pancreas in DCME-treated rats showed improvement in β-cell density compared to diabetic group. The results demonstrate the significant antidiabetic potential of D. cordata leaf in albino rats plausibly by reducing oxidative stress and serum lipids levels, justifying the folkloric use of this plant in the treatment of diabetes.
机译:Drymaria Cordata(蛛网)(血涡轮虫),俗称Abhijalo在Sikkimese-Tibetan,是在世界上热带和亚热带地区种植的匍匐药草。它是由锡金,印度东北印度的族裔群体用于治疗各种疾病,包括糖尿病。本研究旨在探讨甲醇提取物的甲醇提取物从甲醇叶(DCME)在链霉菌(STZ)和烟酰胺(NA)诱导的大鼠中2型糖尿病中的抗糖尿病效应。糖尿病Wistar白化大鼠用DCME以200mg / kg和400mg / kg口服28天用DCME处理。二甲双胍(150mg / kg B.W.)用作参考药物。空腹血糖(FBG)水平;血清生物化学参数;估计肝脏,肾脏和抗氧化剂参数,治疗28天后进行胰腺组织病理学。将DCME施用至STZ-Na诱导的糖尿病大鼠200mg / kg,400mg / kg口服28天表现出统计显着(p <0.05),并依赖于FBG,糖基化血红蛋白,血脂和血管抗氧化与糖尿病对照相比,DCME治疗组中的参数。与糖尿病组相比,DCME处理大鼠胰腺胰腺组织病理学研究显示出β细胞密度的提高。结果证明,通过减少氧化应激和血清脂质水平,证明了与白化大鼠的D.Cordata叶片的显着抗糖尿病潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号